| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Outline of Final Research Achievements |
Rapid progress of RA therapy has been made with molecular inhibitors.However simultaneously, many kinds of biologics were developed, then it has been difficult to select the adequate biologic by both physicians and patients. Therefore we try to detect the makers in serum before starting therapy which can predict the actual efficacy of biologics.
In result, in the case of anti TNF-α inhibitor therapy, the efficacy has been able to predicted on the statistical analysis using Lasso method.Now we know the individual efficacy by selected biologic.
|
